Clinical Trial Update: Sandostatin LAR Depot vs. Surgery for Treating Acromegaly [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing Sandostatin LAR Depot to surgery for acromegaly has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Pituitary Neoplasms

Drugs mentioned

• SANDOSTATIN LAR DEPOT (OCTREOTIDE ACETATE)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Acromegaly, Pituitary Neoplasm | Phase 2 | Status: COMPLETED